$SHL Telemedicine (SHLT.US)$ NEWS Imperial College London St...
NEWS
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
SHL Telemedicine announces groundbreaking results from the Imperial College London TELE-ACS Trial, showing a 76% decrease in hospital readmissions and a 41% decrease in Emergency Department visits for post-MI patients. The trial demonstrated the effectiveness of SHL's SmartHeart® technology in remote cardiac care, with significant reductions in revascularizations and patient-reported symptoms. The study involved 337 participants and was presented at ACC 24 and published in JACC.
Groundbreaking results from the TELE-ACS Trial showcase SHL's SmartHeart® technology reducing hospital readmissions by 76% and ED visits by 41%. Significant decreases in unplanned revascularizations and patient-reported symptoms were observed in the study. The trial, involving 337 participants, sets a new standard in telemedicine for post-ACS patient management. Results were presented at ACC 24 and published in JACC, highlighting the impact of SHL's telemedicine solutions on global patient care.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
456Followers
65Following
2900Visitors
Follow